Finoriq research workspace
MCKESSON CORP (MCK) SEC Filings & Filing Highlights
McKesson Corporation provides healthcare services in the United States and internationally. Review MCK SEC filings, filing highlights, and disclosure activity on Finoriq.
Company Snapshot
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, and hospital reference labs, nursing homes, hospice and home health care agencies, government facilities ,and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
- Company
- MCKESSON CORP (MCK)
- Ticker
- MCK
- Market Cap
- $100.1B
- Latest Price
- $832.61
- Industry
- Other Pharmaceuticals
MCKESSON CORP (MCK) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for MCKESSON CORP (MCK).
| Event | Form | Date |
|---|---|---|
| To support an orderly transition, the company appointed Ramesh Srinivasan as Executive Vice Pre...To support an orderly transition, the company appointed Ramesh Srinivasan as Executive Vice President, Chief Strategy Officer, effective on... | 8-K7.01 | 2026-07-01 |
| Departure of Certain OfficersOn June 29, 2026, Thomas L. Rodgers, the company’s Executive Vice President, Chief Strategy and Business Development Officer and a named ex... | 8-K5.02 | 2026-07-01 |
| MCKESSON CORP: Material agreementOn June 9, 2026, certain of McKesson Corporation’s (the “Company”) subsidiaries, including McKesson Medical-Surgical Top Holdings, Inc. (th... | 8-K1.01 | 2026-06-12 |
| McKESSON REPORTS FISCAL 2026 FOURTH QUARTER AND FULL YEAR RESULTS, PROVIDES FISCAL 2027 GUIDANC...McKESSON REPORTS FISCAL 2026 FOURTH QUARTER AND FULL YEAR RESULTS, PROVIDES FISCAL 2027 GUIDANCE, AND REAFFIRMS LONG-TERM FINANCIAL GROWTH... | 8-K2.02 | 2026-05-07 |
| MCKESSON CORP: Material agreementOn April 24, 2026, McKesson Corporation (“McKesson” or the “Company”) entered into a Credit Agreement (the “New Revolving Credit Facility”)... | 8-K1.01 | 2026-04-28 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.